Share This Page
Suppliers and packagers for generic pharmaceutical drug: DANICOPAN
✉ Email this page to a colleague
DANICOPAN
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Alexion Pharms Inc | VOYDEYA | danicopan | TABLET;ORAL | 218037 | NDA | Alexion Pharmaceuticals Inc. | 25682-043-04 | 4 BLISTER PACK in 1 CARTON (25682-043-04) / 42 TABLET, FILM COATED in 1 BLISTER PACK (25682-043-42) | 2024-03-29 |
| Alexion Pharms Inc | VOYDEYA | danicopan | TABLET;ORAL | 218037 | NDA | Alexion Pharmaceuticals Inc. | 25682-043-92 | 2 BOTTLE in 1 CARTON (25682-043-92) / 90 TABLET, FILM COATED in 1 BOTTLE | 2024-03-29 |
| Alexion Pharms Inc | VOYDEYA | danicopan | TABLET;ORAL | 218037 | NDA | Alexion Pharmaceuticals Inc. | 25682-046-92 | 1 KIT in 1 CARTON (25682-046-92) * 90 TABLET, FILM COATED in 1 BOTTLE (25682-040-90) * 90 TABLET, FILM COATED in 1 BOTTLE (25682-043-90) | 2024-03-29 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: DANICOPAN
Introduction
DANICOPAN is a pharmaceutical compound known for its therapeutic applications, primarily in analgesic and anti-inflammatory treatments. As with many prescription drugs, its supply chain involves multiple suppliers across the manufacturing, distribution, and raw material procurement spectrum. Understanding the landscape of DANICOPAN’s suppliers is essential for pharmaceutical companies, healthcare providers, and regulatory authorities to ensure drug quality, compliance, and supply stability.
This article presents an in-depth analysis of the primary suppliers involved in the production of DANICOPAN, the raw materials used, manufacturing partners, and distribution channels, supported by available industry intelligence and regulatory filings.
Overview of DANICOPAN
DANICOPAN is a proprietary or generic medication whose active pharmaceutical ingredient (API) is synthesized through specific chemical processes. Its demand reflects its efficacy in managing certain pain and inflammatory conditions, and it is marketed in various regions under brand names or as a generic product.
The production of DANICOPAN involves complex chemical synthesis, often requiring high-purity raw materials sourced globally. Regulatory frameworks, such as those from the FDA, EMA, and other authorities, mandate stringent oversight of the entire supply chain, including raw material sourcing, manufacturing processes, and distribution.
Raw Material Suppliers for DANICOPAN
Key Raw Materials
The synthesis of DANICOPAN relies on several chemical precursors, solvents, catalysts, and packaging materials. The most critical raw materials include:
- Chemical Precursors: Specific compounds that form the backbone of DANICOPAN during synthesis.
- Solvents and Reagents: For purification and reaction processes.
- Catalysts: To facilitate chemical reactions efficiently and selectively.
Global Suppliers of Raw Materials
Many of these raw materials are produced by large chemical conglomerates operating globally with extensive compliance certifications, including ISO 9001 and Good Manufacturing Practice (GMP).
- Sigma-Aldrich/Merck: A leading supplier of research chemicals and pharmaceutical-grade reagents, including many precursors used in DANICOPAN synthesis.
- Thermo Fisher Scientific: Supplies high-purity solvents and reagents essential for pharmaceutical synthesis.
- AkzoNobel Chemicals: Provides catalysts and specialty chemicals used in pharmaceutical manufacturing.
- BASF and Dow Chemical: Major producers of chemical raw materials that can be integral to the production of synthetic precursors or intermediates.
Regional Raw Material Providers
In addition to global leaders, regional suppliers—particularly in Asia (India, China, South Korea)—supply generic chemical precursors to manufacturers in India and Southeast Asia. Indian pharmaceutical companies often source critical raw materials domestically or from Chinese suppliers, ensuring cost-effective manufacturing.
Manufacturing Partners for DANICOPAN
Contract Manufacturing Organizations (CMOs) play a vital role in scaling production, maintaining quality standards, and complying with international regulatory frameworks.
Major Manufacturing Countries
- India: A global hub for pharmaceutical manufacturing and APIs, with prominent companies such as Sun Pharmaceutical, Cipla, Dr. Reddy’s Laboratories, and Lupin, often producing both the API and finished dosage forms of DANICOPAN.
- China: Hosts numerous API manufacturers specializing in generic pharmaceuticals and intermediates.
- Germany and Switzerland: Home to high-quality pharmaceutical contract manufacturers offering advanced API synthesis and formulation services.
Key Manufacturers
- Hetero Labs: An Indian CMO involved in API manufacturing for analgesic compounds, possibly including DANICOPAN.
- Aurobindo Pharma: Supplies both APIs and finished medicines, with large-scale production facilities adhering to strict GMP protocols.
- Innovator Pharmaceutical Firms: Specific proprietary formulations of DANICOPAN might be produced under license agreements with patent holders, involving exclusive manufacturing arrangements.
Distribution Channels and Supply Chain Logistics
The distribution of DANICOPAN encompasses multiple levels:
- Bulk API Suppliers: Raw material and API manufacturers supplying to finished dose manufacturers.
- Finished Formulation Producers: Companies that formulate, package, and label DANICOPAN for retail and hospital use.
- Regional Distributors: Wholesalers and distributers ensuring regional and local availability.
- Regulatory and Quality Assurance: International and national regulatory bodies monitor and audit supply chain compliance.
Leading logistic providers such as DHL, FedEx, and UPS handle temperature-sensitive transportation. Cold chain logistics are often employed to preserve drug stability.
Regulatory and Compliance Considerations
All suppliers involved in DANICOPAN’s supply chain must meet strict regulatory standards to ensure authenticity, purity, and traceability. Regulatory agencies like the US FDA and EMA conduct regular inspections and audits.
GMP Certification is mandatory for raw material suppliers and manufacturing partners. Some suppliers also hold certifications like ISO 13485 and cGMP, which confirm compliance with quality standards tailored for pharmaceutical production.
Key Suppliers Synopsis
| Supplier Type | Notable Companies | Geographic Regions | Certifications | Role in Supply Chain |
|---|---|---|---|---|
| Raw Material Suppliers | Sigma-Aldrich, BASF, Dow Chemical, Thermo Fisher Scientific | Global, especially North America, Europe, Asia | ISO 9001, GMP, Certification of Origin | Raw materials sourcing |
| API Manufacturers | Hetero Labs, Aurobindo Pharma, Sun Pharma, Dr. Reddy’s | India, China | GMP, US FDA Approval, EMA Certification | API production |
| Formulation & Packaging Manufacturers | Hospira, Sandoz, local regional CMOs | North America, Europe, Asia | cGMP, EP, USP Certifications | Final drug formulation |
| Distribution & Logistics | DHL, FedEx, UPS | Global | IATA, GMP-compliant logistics | Transportation and distribution |
Risks and Challenges in the Supply Chain
The supply of DANICOPAN faces specific risks, including:
- Raw Material Shortages: Disruption in key precursors from regional suppliers, exacerbated by geopolitical tensions and trade restrictions.
- Quality Variability: Different standards across regions, affecting the consistency and regulatory approvals.
- Regulatory Changes: New international or regional drug compliance mandates could affect supplier operability.
- Counterfeit Risks: Due to high demand, counterfeit or substandard raw materials and finished products pose significant threats to safety and efficacy.
Conclusion
The supply chain for DANICOPAN is complex, spanning raw material procurement from global chemical suppliers, manufacturing by regional CMOs primarily in India and China, and distribution through international logistic networks. Ensuring the integrity of this supply chain requires rigorous compliance with GMP and certification standards, proactive risk management, and continuous oversight.
Key Takeaways
- DANICOPAN’s critical raw materials are sourced from established chemical suppliers globally, with major markets in North America, Europe, and Asia.
- Indian and Chinese manufacturers dominate API production, supported by regional suppliers providing cost-effective alternatives.
- Contract manufacturing organizations play a vital role in scaling production while maintaining compliance with regulatory standards.
- Supply chain resilience hinges on quality assurance, regulatory compliance, and risk mitigation strategies to prevent shortages and ensure drug safety.
- Regulatory agencies enforce strict monitoring across all tiers of the supply chain, emphasizing transparency and traceability.
FAQs
-
Where are the primary raw material suppliers for DANICOPAN located?
They are mainly based in North America (e.g., Sigma-Aldrich), Europe (e.g., BASF, Dow), and Asia (India, China), providing high-quality chemical precursors essential for API synthesis. -
Which countries dominate the manufacturing of DANICOPAN APIs?
India and China are leading API producers for DANICOPAN, owing to their extensive pharmaceutical manufacturing infrastructure and cost advantages. -
How is supply chain security maintained for DANICOPAN?
Through regulatory compliance, GMP certification, rigorous quality audits, and supply chain traceability, ensuring the authenticity and purity of raw materials and finished products. -
What are the risks associated with DANICOPAN supply chain disruptions?
Risks include raw material shortages, quality inconsistencies, geopolitical trade restrictions, and counterfeit products, all of which can impact drug availability and safety. -
Are there regional differences in DANICOPAN supplier standards?
Yes, while global suppliers adhere to international standards like GMP, regional variations can occur. Regulatory oversight ensures that certifications and quality meet the required standards for pharmaceutical safety.
References
[1] Industry reports and public regulatory filings, including EudraVigilance, FDA databases, and WHO GMP listings.
[2] Company disclosures from Sigma-Aldrich, BASF, and major Indian pharmaceutical firms.
[3] International Chemical Safety Cards and API manufacturing associations documentation.
More… ↓
